NES
CELG

New England Securities’s Celgene Corp CELG Stock Holding History

New England Securities’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$207K Sell
1,850
-627
-25% -$66.1K 0.07% 266
2014
Q3 		$235K Buy
2,477
+194
+8% +$17.5K 0.08% 249
2014
Q2 		$196K Buy
2,283
+101
+5% +$7.68K 0.07% 310
2014
Q1 		$152K Buy
2,182
+294
+16% +$23.3K 0.06% 315
2013
Q4 		$160K Buy
1,888
+920
+95% +$72.8K 0.07% 296
2013
Q3 		$75K Sell
968
-40
-4% -$2.8K 0.04% 416
2013
Q2 		$59K Buy
+1,008
New +$60.7K 0.04% 391

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

New England Securities's CELG Position: Q4 2014 in Review

New England Securities reduced its Celgene Corp (CELG) stake by 25% in Q4 2014, selling an estimated $66.1K and leaving 1,850 shares worth $207K. The position accounts for 0.07% of the portfolio, ranked #266.

New England Securities first reported a position in CELG in Q2 2013 and has held it in 7 quarters since. The position peaked at $235K in Q3 2014. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • New England Securities held 1,850 shares of Celgene Corp worth $207K as of Q4 2014.
  • New England Securities sold 627 Celgene Corp shares in Q4 2014, an estimated $66.1K.
  • Celgene Corp made up 0.07% of New England Securities's portfolio in Q4 2014, its #266 holding.
  • New England Securities first reported a position in Celgene Corp in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Celgene Corp position peaked at $235K in Q3 2014.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.